Andrew F Scarsbrook (Andrew Scarsbrook, A Scarsbrook)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 25

Top Topics

Locally Advanced

Magnetic Resonance

Radiation Induced

Top Venues

Prostate cancer and prostatic diseases

Current oncology (Toronto, Ont.)

This page only lists publications with an associated author ORCID identifier.

Publications

Simran Singh Dhesi, Russell Frood, Sarah Swift, Rachel Cooper, Siddhant Muzumdar, Mehvish Jamal, Andrew F Scarsbrook
Prediction of Patient Outcomes in Locally Advanced Cervical Carcinoma Following Chemoradiotherapy-Comparative Effectiveness of Magnetic Resonance Imaging and 2-Deoxy-2-[ 18 F]fluoro-D-glucose Imaging. Cancers 16 (3) (2024)
Kavi Fatania, Russell Frood, Hitesh B Mistry, Susan C Short, James O'Connor, Andrew F Scarsbrook, Stuart Currie
Tumour Size and Overall Survival in a Cohort of Patients with Unifocal Glioblastoma: A Uni- and Multivariable Prognostic Modelling and Resampling Study. Cancers 16 (7) (2024)
Simran Singh Dhesi, Russell Frood, Sarah Swift, Rachel Cooper, Siddhant Muzumdar, Mehvish Jamal, Andrew F Scarsbrook
Prediction of Patient Outcomes in Locally Advanced Cervical Carcinoma Following Chemoradiotherapy-Comparative Effectiveness of Magnetic Resonance Imaging and 2-Deoxy-2-[ 18 F]fluoro-D-glucose Imaging. Cancers 16 (3) (2024)
Simran Singh Dhesi, Russell Frood, Sarah Swift, Rachel Cooper, Siddhant Muzumdar, Mehvish Jamal, Andrew F Scarsbrook
Prediction of Patient Outcomes in Locally Advanced Cervical Carcinoma Following Chemoradiotherapy-Comparative Effectiveness of Magnetic Resonance Imaging and 2-Deoxy-2-[ 18 F]fluoro-D-glucose Imaging. Cancers 16 (3) (2024)
Simran Singh Dhesi, Russell Frood, Sarah Swift, Rachel Cooper, Siddhant Muzumdar, Mehvish Jamal, Andrew F Scarsbrook
Prediction of Patient Outcomes in Locally Advanced Cervical Carcinoma Following Chemoradiotherapy-Comparative Effectiveness of Magnetic Resonance Imaging and 2-Deoxy-2-[ 18 F]fluoro-D-glucose Imaging. Cancers 16 (3) (2024)
Kavi Fatania, Russell Frood, Hitesh B Mistry, Susan C Short, James O'Connor, Andrew F Scarsbrook, Stuart Currie
Tumour Size and Overall Survival in a Cohort of Patients with Unifocal Glioblastoma: A Uni- and Multivariable Prognostic Modelling and Resampling Study. Cancers 16 (7) (2024)
Kavi Fatania, Russell Frood, Hitesh B Mistry, Susan C Short, James O'Connor, Andrew F Scarsbrook, Stuart Currie
Tumour Size and Overall Survival in a Cohort of Patients with Unifocal Glioblastoma: A Uni- and Multivariable Prognostic Modelling and Resampling Study. Cancers 16 (7) (2024)
Jack Breen, Katie Allen, Kieran Zucker, Pratik Adusumilli, Andrew F Scarsbrook, Geoff Hall, Nicolas M Orsi, Nishant Ravikumar
Artificial intelligence in ovarian cancer histopathology: a systematic review. NPJ precision oncology 7 (1) (2023)
Lisa M Duff, Andrew F Scarsbrook, Nishant Ravikumar, Russell Frood, Gijs D van Praagh, Sarah L Mackie, Marc A Bailey, Jason M Tarkin, Justin C Mason, Kornelis S M van der Geest, Riemer H J A Slart, Ann W Morgan, Charalampos Tsoumpas
An Automated Method for Artifical Intelligence Assisted Diagnosis of Active Aortitis Using Radiomic Analysis of FDG PET-CT Images. Biomolecules 13 (2) (2023)
Sarah Billingsley, Zsuzsanna Iyizoba, Russell Frood, Sriram Vaidyanathan, Robin J D Prestwich, Andrew F Scarsbrook
Clinical Utility of Second-Look FDG PET-CT to Stratify Incomplete Metabolic Response Post (Chemo) Radiotherapy in Oropharyngeal Squamous Cell Carcinoma. Cancers 15 (2) (2023)
Lisa M Duff, Andrew F Scarsbrook, Nishant Ravikumar, Russell Frood, Gijs D van Praagh, Sarah L Mackie, Marc A Bailey, Jason M Tarkin, Justin C Mason, Kornelis S M van der Geest, Riemer H J A Slart, Ann W Morgan, Charalampos Tsoumpas
An Automated Method for Artifical Intelligence Assisted Diagnosis of Active Aortitis Using Radiomic Analysis of FDG PET-CT Images. Biomolecules 13 (2) (2023)
Stuart Currie, Kavi Fatania, Russell Frood, Ruth Whitehead, Joanna Start, Ming-Te Lee, Benjamin McDonald, Kate Rankeillor, Paul Roberts, Aruna Chakrabarty, Ryan Koshy Mathew, Louise Murray, Susan Short, Andrew F Scarsbrook
Imaging Spectrum of the Developing Glioblastoma: A Cross-Sectional Observation Study. Current oncology (Toronto, Ont.) 30 (7) (2023)
Lisa M Duff, Andrew F Scarsbrook, Nishant Ravikumar, Russell Frood, Gijs D van Praagh, Sarah L Mackie, Marc A Bailey, Jason M Tarkin, Justin C Mason, Kornelis S M van der Geest, Riemer H J A Slart, Ann W Morgan, Charalampos Tsoumpas
An Automated Method for Artifical Intelligence Assisted Diagnosis of Active Aortitis Using Radiomic Analysis of FDG PET-CT Images. Biomolecules 13 (2) (2023)
Sarah Billingsley, Zsuzsanna Iyizoba, Russell Frood, Sriram Vaidyanathan, Robin J D Prestwich, Andrew F Scarsbrook
Clinical Utility of Second-Look FDG PET-CT to Stratify Incomplete Metabolic Response Post (Chemo) Radiotherapy in Oropharyngeal Squamous Cell Carcinoma. Cancers 15 (2) (2023)
Lisa M Duff, Andrew F Scarsbrook, Nishant Ravikumar, Russell Frood, Gijs D van Praagh, Sarah L Mackie, Marc A Bailey, Jason M Tarkin, Justin C Mason, Kornelis S M van der Geest, Riemer H J A Slart, Ann W Morgan, Charalampos Tsoumpas
An Automated Method for Artifical Intelligence Assisted Diagnosis of Active Aortitis Using Radiomic Analysis of FDG PET-CT Images. Biomolecules 13 (2) (2023)
Lisa M Duff, Andrew F Scarsbrook, Nishant Ravikumar, Russell Frood, Gijs D van Praagh, Sarah L Mackie, Marc A Bailey, Jason M Tarkin, Justin C Mason, Kornelis S M van der Geest, Riemer H J A Slart, Ann W Morgan, Charalampos Tsoumpas
An Automated Method for Artifical Intelligence Assisted Diagnosis of Active Aortitis Using Radiomic Analysis of FDG PET-CT Images. Biomolecules 13 (2) (2023)
Russell Frood, Matthew Clark, Cathy Burton, Charalampos Tsoumpas, Alejandro F Frangi, Fergus Gleeson, Chirag Patel, Andrew F Scarsbrook
Discovery of Pre-Treatment FDG PET/CT-Derived Radiomics-Based Models for Predicting Outcome in Diffuse Large B-Cell Lymphoma. Cancers 14 (7) (2022)
Sarah R Brown, Samantha Hinsley, Emma C Hall, Christopher N Hurt, Richard D Baird, Martin Forster, Andrew F Scarsbrook, Richard A Adams
A Road Map for Designing Phase I Clinical Trials of Radiotherapy-Novel Agent Combinations. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (17) (2022)
Jim Zhong, Sarah R Brown, Maria Serra, Pam Shuttleworth, Peter Bownes, Christopher Thompson, Rachel Reed, Kimberley Reeves, Michael J Dubec, Damien J McHugh, Cynthia L Eccles, Robert Chuter, Yat Man Tsang, N Jane Taylor, Catharine M L West, David L Buckley, Andrew F Scarsbrook, Ananya Choudhury, Peter J Hoskin, Ann Henry
Reirradiation Options for Previously Irradiated Prostate cancer (RO-PIP): Feasibility study investigating toxicity outcomes following reirradiation with stereotactic body radiotherapy (SBRT) versus high-dose-rate brachytherapy (HDR-BT). BMJ open 12 (11) (2022)
Kavi Fatania, Russell Frood, Marcus Tyyger, Garry McDermott, Sharon Fernandez, Gary C Shaw, Marjorie Boissinot, Daniela Salvatore, Luisa Ottobrini, Irvin Teh, John Wright, Marc A Bailey, Joanna Koch-Paszkowski, Jurgen E Schneider, David L Buckley, Louise Murray, Andrew F Scarsbrook, Susan C Short, Stuart Currie
Exploratory Analysis of Serial 18 F-fluciclovine PET-CT and Multiparametric MRI during Chemoradiation for Glioblastoma. Cancers 14 (14) (2022)
Zsuzsanna Iyizoba-Ebozue, Sarah Billingsley, Russell Frood, Sriram Vaidyanathan, Andrew F Scarsbrook, Robin J D Prestwich
Accuracy of Response Assessment FDG PET-CT Post (Chemo)Radiotherapy in HPV Negative Oropharynx Squamous Cell Carcinoma. Cancers 14 (19) (2022)
Soroush Rais-Bahrami, Jason A Efstathiou, Catriona M Turnbull, Stephen B Camper, Andy Kenwright, David M Schuster, Andrew F Scarsbrook
18F-Fluciclovine PET/CT performance in biochemical recurrence of prostate cancer: a systematic review. Prostate cancer and prostatic diseases 24 (4) (2021)
Stephanie Rose Harrison, J R L Klassen, Charles Bridgewood, Andrew F Scarsbrook, Helena Marzo-Ortega, Dennis G McGonagle
Chest pain mimicking pulmonary embolism may be a common presentation of COVID-19 in ambulant patients without other typical features of infection. Journal of internal medicine 290 (2) (2021)
Andrew F Scarsbrook, Gillian Ward, Patrick Murray, Rebecca Goody, Karen Marshall, Garry McDermott, Robin Prestwich, Ganesh Radhakrishna
Respiratory-gated (4D) contrast-enhanced FDG PET-CT for radiotherapy planning of lower oesophageal carcinoma: feasibility and impact on planning target volume. BMC cancer 17 (1) (2017)
Andrew F Scarsbrook, Sriram Vaidyanathan, Fahmid Chowdhury, Sarah Swift, Rachel Cooper, Chirag Patel
Efficacy of qualitative response assessment interpretation criteria at 18F-FDG PET-CT for predicting outcome in locally advanced cervical carcinoma treated with chemoradiotherapy. European journal of nuclear medicine and molecular imaging 44 (4) (2016)